251 related articles for article (PubMed ID: 28709531)
1. Bone Margin Analysis for Osteonecrosis and Osteomyelitis of the Jaws.
Qaisi M; Montague L
Oral Maxillofac Surg Clin North Am; 2017 Aug; 29(3):301-313. PubMed ID: 28709531
[TBL] [Abstract][Full Text] [Related]
2. Osteoclast profile of medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis.
Gross C; Weber M; Creutzburg K; Möbius P; Preidl R; Amann K; Wehrhan F
J Transl Med; 2017 Jun; 15(1):128. PubMed ID: 28587628
[TBL] [Abstract][Full Text] [Related]
3. Suppurative osteomyelitis, bisphosphonate induced osteonecrosis, osteoradionecrosis: a blinded histopathologic comparison and its implications for the mechanism of each disease.
Marx RE; Tursun R
Int J Oral Maxillofac Surg; 2012 Mar; 41(3):283-9. PubMed ID: 22244079
[TBL] [Abstract][Full Text] [Related]
4. Parathyroid hormone may be a promising therapy for bisphosphonate-related osteonecrosis of jaw bones.
Li YF; Hu J
Int J Oral Maxillofac Surg; 2013 Jan; 42(1):149-50. PubMed ID: 22763138
[No Abstract] [Full Text] [Related]
5. A commentary on "Suppurative osteomyelitis, bisphosphonate induced osteonecrosis, osteoradionecrosis: a blinded histopathologic comparison and its implications for the mechanism of each disease" by R.E. Marx and R. Tursun [Int. J. Oral Maxillofac. Surg. 41 (2012) 283-289].
Kalmar JR
Int J Oral Maxillofac Surg; 2013 Jan; 42(1):147-8. PubMed ID: 23107998
[No Abstract] [Full Text] [Related]
6. Response to - a commentary on "Suppurative osteomyelitis, bisphosphonate induced 1 osteonecrosis, osteoradionecrosis: a blinded histopathologic comparison and its 2 implications for the mechanism of each disease" by R.E. Marx and R. Tursun [Int. J. Oral. Maxillofac. Surg. 41 (3) (2012) 283-289].
Marx RE; Tursun R
Int J Oral Maxillofac Surg; 2013 Jan; 42(1):148-9. PubMed ID: 23219001
[No Abstract] [Full Text] [Related]
7. Osteoclastic expression of higher-level regulators NFATc1 and BCL6 in medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis.
Wehrhan F; Gross C; Creutzburg K; Amann K; Ries J; Kesting M; Geppert CI; Weber M
J Transl Med; 2019 Mar; 17(1):69. PubMed ID: 30832685
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the histopathological characteristics of osteomyelitis, medication-related osteonecrosis of the jaw, and osteoradionecrosis.
Shuster A; Reiser V; Trejo L; Ianculovici C; Kleinman S; Kaplan I
Int J Oral Maxillofac Surg; 2019 Jan; 48(1):17-22. PubMed ID: 30054185
[TBL] [Abstract][Full Text] [Related]
9. Radiologic findings of osteonecrosis, osteoradionecrosis, osteomyelitis and jaw metastatic disease with cone beam CT.
Yfanti Z; Tetradis S; Nikitakis NG; Alexiou KE; Makris N; Angelopoulos C; Tsiklakis K
Eur J Radiol; 2023 Aug; 165():110916. PubMed ID: 37300936
[TBL] [Abstract][Full Text] [Related]
10. Medication-related osteonecrosis of the jaw, osteoradionecrosis, and osteomyelitis: A comparative histopathological study.
De Antoni CC; Matsumoto MA; Silva AAD; Curi MM; Santiago Júnior JF; Sassi LM; Cardoso CL
Braz Oral Res; 2018; 32():e23. PubMed ID: 29723337
[TBL] [Abstract][Full Text] [Related]
11. Tetraparesis after surgical treatment of bisphosphonate-associated osteonecrosis of the jaw.
Zaami S; Busardò FP; Amatruda A; Ricci G; Esposito V
J Neurosurg Sci; 2018 Feb; 62(1):97-99. PubMed ID: 27057695
[No Abstract] [Full Text] [Related]
12. Risk Factors for Infection Recurrence After Surgical Resection of Advanced Stage Osteonecrosis of the Mandible.
Doub JB; Kang A; Lee C; Dyalram D; Shih P; Twaddell WS; Lubek JE
J Oral Maxillofac Surg; 2024 Mar; 82(3):332-340. PubMed ID: 38199239
[TBL] [Abstract][Full Text] [Related]
13. Radiologic findings of osteonecrosis, osteoradionecrosis, osteomyelitis and jaw metastatic disease with cone beam CT.
Yfanti Z; Tetradis S; Nikitakis NG; Eleni Alexiou K; Makris N; Angelopoulos C; Tsiklakis K
Eur J Radiol; 2024 Apr; 173():111387. PubMed ID: 38428257
[No Abstract] [Full Text] [Related]
14. Management of osteonecrosis of the jaws induced by radiotherapy in oncological patients: preliminary results.
Manzon L; Rossi E; Fratto G
Eur Rev Med Pharmacol Sci; 2015; 19(2):194-200. PubMed ID: 25683930
[TBL] [Abstract][Full Text] [Related]
15. Letter to the Editor regarding "Radiologic findings of osteonecrosis, osteoradionecrosis, osteomyelitis and jaw metastatic disease with cone beam CT".
Yilmaz B; Topkan E
Eur J Radiol; 2023 Nov; 168():111123. PubMed ID: 37806191
[No Abstract] [Full Text] [Related]
16. Differences between osteoradionecrosis and medication-related osteonecrosis of the jaw.
Akashi M; Wanifuchi S; Iwata E; Takeda D; Kusumoto J; Furudoi S; Komori T
Oral Maxillofac Surg; 2018 Mar; 22(1):59-63. PubMed ID: 29224060
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of SPECT/CT in the assessment of inflammatory jaw pathologies.
Modabber A; Schick D; Möhlhenrich SC; Mottaghy FM; Verburg FA; Hölzle F; Gerressen M
Eur J Radiol; 2020 Apr; 125():108917. PubMed ID: 32120276
[TBL] [Abstract][Full Text] [Related]
18. Osteonecrosis of the jaws in patients treated with bisphosphonates - histomorphologic analysis in comparison with infected osteoradionecrosis.
Hansen T; Kunkel M; Weber A; James Kirkpatrick C
J Oral Pathol Med; 2006 Mar; 35(3):155-60. PubMed ID: 16454811
[TBL] [Abstract][Full Text] [Related]
19. Bone single-photon emission computed tomography-CT peak standardized uptake value for chronic osteomyelitis, osteoradionecrosis and medication-related osteonecrosis of the jaw.
Minami Y; Ogura I
J Med Imaging Radiat Oncol; 2021 Apr; 65(2):160-165. PubMed ID: 33180378
[TBL] [Abstract][Full Text] [Related]
20. Increased human defensine levels hint at an inflammatory etiology of bisphosphonate-associated osteonecrosis of the jaw: an immunohistological study.
Stockmann P; Wehrhan F; Schwarz-Furlan S; Stelzle F; Trabert S; Neukam FW; Nkenke E
J Transl Med; 2011 Aug; 9():135. PubMed ID: 21843332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
